Microarray ISO/IEC first signals shift in clinical use
This article was originally published in Clinica
Almac Diagnostics is the first company to gain UK accreditation for gene expression microarray and bioinformatics analysis services, under the ISO/IEC 17025:2005 standard. The move is seen by the United Kingdom Accreditation Service (UKAS) as underpinning a shift towards greater use of microarray technology in the clinical diagnostics setting.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.